Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests. The drug, ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Separate study finds GLP-1 medicines combined with bariatric surgery may significantly reduce risk of serious cardiovascular ...

The weight loss injection Wegovy slashed the risk of heart attack and heart disease, even before patients ... even expect to see highest doses of semaglutide. So we’re starting to see this ...

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

The drug, which contains the active ingredient semaglutide ... a clinical trial found it reduced the risk of having a heart attack, stroke or heart disease death by 37% in people with obesity ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food cravings ...